Mitochondria and vision – a life in mitochondria always on the move

Marcela Votruba

DOI: https://doi.org/10.1111/aos.16264

2024-01-01

Acta Ophthalmologica

Abstract:Mitochondrial disease is among the most common form of inherited neurological disorder, with a minimum prevalence of 1:5000 and few if any effective treatments or cures. Mitochondria are highly dynamic organelles undergoing coordinated cycles of fission and fusion, referred as ‘mitochondrial dynamics’, in order to maintain their shape, distribution and size. Mitochondrial dysfunction is seen in numerous diseases, including rare primary genetic mitochondrial diseases, many affecting the eye and vision and various common degenerative disorders. Mitochondrial dysfunction is implicated in the ageing process and also contributes to ischaemic cardiac disease and cancer. Mitochondrial dysfunction has been well documented in neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, glaucoma and age‐related macular degeneration. Consequently, it is now becoming a major target for new therapeutic development. To date, however, there have been few if any successes. The problems faced in addressing mitochondrial dysfunction range from identifying suitable targets to lack of methods that reliably transfect mitochondria. There may be huge potential in taking an advanced therapy medicinal products (ATMPs) approach, developing medicines for human use that are based on genes, tissues or cells. A novel approach in the literature is the transplantation of fully functional mitochondria directly into defective cells. Could this be the more generic solution that would address the diverse range of mitochondrial defects in disease?

ophthalmology